glp-1 agonist drugs New Guidelines for Type 2 Diabetes in 2025 Evolution of GLP‐1 Receptor Agonists

The investigation specifically showed that these drugs did not increase the risk of any fractures, confirming their safety profile in clinical practice ( 4.6 Ophthalmological effects 4.6.1 Glaucoma GLP-1R agonists exhibit anti-inflammatory and neuroprotective properties, suggesting they could also be beneficial in neurodegenerative diseases ( A recent registry-based case-control study, summarized in Table 2 , involving 1,961 patients found that the use of GLP-1R agonists is linked to a lower risk of glaucoma (Sterling et al., 2021 (79)

Insurance coverage can be more challenging than semaglutide

The active component Procyanidins is administered to Wistar rats at a dose of 500 mg/kg for research purposes, resulting in an increase in plasma GLP-1 levels in rats [19]

28 The overall metabolic improvement is indeed beneficial for MASLD

After two years (120 weeks), the patients retained roughly one-third of their original weight loss (5.6% of the original 17.3% loss)

We offer personalised advice on portion control and physical activity, which promotes long-term success